Range
32 - 34.29
Vol / Avg.
861.3K/498.9K
Div / Yield
-
52 Wk
17.2 - 32.31
Mkt Cap
1.8B
Payout Ratio
-
Open
32
P/E
15.42
EPS
0.11
Shares
53M
Outstanding
53M
Total Float
36.9M
load more
Sector: Health Care.Industry: Pharmaceuticals
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The company products include Oxtellar XR, Trokendi XR, SPN-812, and others. The majority of the revenue is generated from the sale of Trokendi XR.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-17
REV
Q1 2021Est.ActualSurprise
EPS0.2400.110 -0.1300
REV129.200M130.932M1.732M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
SUPNSupernus Pharmaceuticals3.98%1.8B

Supernus Pharmaceuticals Frequently Asked Questions

Q

How do I buy Supernus Pharmaceuticals (SUPN) stock?

A

You can purchase shares of Supernus Pharmaceuticals (NASDAQ: SUPN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Supernus Pharmaceuticals's (SUPN) competitors?

Q

What is the target price for Supernus Pharmaceuticals (SUPN) stock?

A

The latest price target for Supernus Pharmaceuticals (NASDAQ: SUPN) was reported by Jefferies on April 13, 2021. The analyst firm set a price target for 40.00 expecting SUPN to rise to within 12 months (a possible 20.52% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Supernus Pharmaceuticals (SUPN)?

A

The stock price for Supernus Pharmaceuticals (NASDAQ: SUPN) is $33.19 last updated Wed Jun 16 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does Supernus Pharmaceuticals (SUPN) pay a dividend?

A

There are no upcoming dividends for Supernus Pharmaceuticals.

Q

When is Supernus Pharmaceuticals (NASDAQ:SUPN) reporting earnings?

A
Supernus Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 17, 2021.
Q

Is Supernus Pharmaceuticals (SUPN) going to split?

A

There is no upcoming split for Supernus Pharmaceuticals.

Q

What sector and industry does Supernus Pharmaceuticals (SUPN) operate in?

A

Supernus Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.